Scholars Central

Conference abstractPublished 4 Jul 2022

Non-coding RNAs as potential diagnostic and therapeutic targets in cancer: Modulatory effect of miRNA inhibitors on oncomiRs in breast cancer

Authors: Amr M. Abdelhamid

Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Egypt

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The regulatory mechanisms of oncomiR and tumour suppressor microRNAs play a critical role in carcinogenesis events. Increased expression of oncomiR in cancerous cells inhibits tumour suppressor genes, while decreased expression of tumour suppressor miRNAs potentially enhances the expression of oncogenes. Early-stage detection of BC is a critical factor for effective treatment of the disease and can increase the survival rate of BC patients. Maternally expressed 3 (MEG3) is a long non-coding RNA (LnCRNA) can act as a decoy by sequestering miRNAs-29 and 182 and it was reported to be a tumour suppressor in breast cancer. In BC, overexpression of miR-29 inhibits the expression of PTEN: the tumour suppressor. The deregulation of the expression of miRNAs has been shown to pave the way for the development of miRNA-based anti-cancer therapeutics. MEG3 rs7158663 G/A was genotyped and serum MEG3, miRNA-182, and miRNA-29 were measured in breast cancers, fibroadenoma, and controls by qPCR. The results showed that serum MEG3 levels were significantly decreased, according to the presence of the A allele in different study groups, while the expression of miR-182 and miRNA 29 was significantly elevated. In conclusion, MEG3, miR-182 and miRNA-29 are key genes involved in the development of BC and are considered novel potential non-invasive diagnostic biomarkers for BC. MiRNA-29 inhibitor is an anti-miRNA oligonucleotide that can directly bind to its target miRNA-29 (oncomiR) and block its function, restoring the expression levels of PTEN, which promotes apoptosis and inhibits tumour cell migration and invasion. Key words: LnCRNA – miRNA-inhibitor – OncomiR- BC

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Amr M. Abdelhamid”